Fuller & Thaler Asset Management
AUXL

Fuller & Thaler Asset Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Fuller & Thaler Asset Management’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-85,000
Closed -$1.55M – 657
2013
Q3 		$1.55M Sell
85,000
-210,900
-71% -$3.81M 0.09% 224
2013
Q2 		$4.92M Buy
+295,900
New +$4.73M 0.35% 124

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management's AUXL Position: Q4 2013 in Review

Fuller & Thaler Asset Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2013, closing a stake of 85,000 shares — an estimated $1.55M sold.

Fuller & Thaler Asset Management first reported a position in AUXL in Q2 2013 and held it in 2 quarters. The position peaked at $4.92M in Q2 2013. 147 funds tracked by Wall St. Rank hold AUXL as of Q4 2013.

  • Fuller & Thaler Asset Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 85,000 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2013, an estimated $1.55M.
  • Fuller & Thaler Asset Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Fuller & Thaler Asset Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $4.92M in Q2 2013.
  • 147 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2013.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2013, filed 13 Feb 2014.